Becker's Healthcare July 8, 2024
Pharmaceutical company Eli Lilly plans to acquire Morphic, a biopharmaceutical company that specializes in treating gastroenterology patients, for $3.2 billion.
Morphic’s lead program is an oral treatment for inflammatory bowel disease patients, according to...